A research team has discovered a new mechanism and drug combination strategy that can effectively treat osteoporosis, a ...

Proceeds will help enhance workflows and expand single-cell functional assay portfolio * Brad Crutchfield joins as advisor to support early access ...

Tempus AI TEM shares are up on Tuesday as the company announced the acceptance of 31 abstracts for presentation at the ...

Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...

Lightcast, a pioneering life science tools company focused on functional single-cell analysis, today announced the closing of a $27 million financing raised from existing investors. The financing was ...

The development of tendon tissue engineering and regenerative medicine depends heavily on whether in vitro mechanical stimulation can faithfully ...

Cambridge-based life sciences specialist Lightcast has raised $27 million from global backers to swell its total funding to ...

Scientists are uncovering a surprising connection between autism and ADHD that goes deeper than labels. Instead of diagnoses, it’s the severity of autism-like traits that seems to shape how the brain ...

An octopus-shaped nanomachine hijacks tumor ATP leakage to power a self-amplifying cycle of membrane damage, drug delivery, and metabolic collapse in cancer cells.

Can Rett syndrome be treated with precision medicine? A new study using brain organoids shows that mutations R306C and V247X require different drugs, HDAC2 inhibitors and baclofen, to restore brain ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

Helical has raised $10M to build the application layer that makes bio foundation models reproducible in pharma R&D. It’s ...